CannabisNewsBreaks – Canna-V-Cell Sciences Inc. (CSE: CNVC) Achieves Significant Milestone in 16-Month Program

September 5, 2019 10:42:20

Canna-V-Cell Sciences (CSE: CNVC) (“CannaVcell”) recently announced its achievement of a significant milestone of having cannabis trichomes at the suspension phase. According to the update, CannaVcell, on October 2018, embarked on a 16 months program to prove the feasibility of applying its unique Biofarming technology on cannabis. “This clearly confirms that the progress made to-date towards the completion of the 16 months development program has exceeded the expectations,” CannaVcell CTO Dr. Yochi Hagay said in the news release. “We can now be assured that the goals of the program will be achieved ahead of schedule.”

To view the full press release, visit

About Canna-V-Cell Sciences Inc.

Based in Vancouver BC, Canna-V-Cell Sciences Inc. is the exclusive Cannabis worldwide licensee of the proprietary and patent protected BioHarvest technology. It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. By adopting this technology and building adequate cells production capacity, Canna-V-Cell’s objective is to become the leading supplier of Cannabis for both the medicinal and recreational legal use. For more information, visit the company’s website at

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
905.674.5977 Office